[1] |
Yancong Zhao, Li Wang, Jingjing Zeng, Jinghua Li.
The structure and antiproliferative activity of the inclusion complex of neoandrographolide/β-cyclodextrin
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(6): 427-434.
|
[2] |
Lu Shi, Feng Miao, Guopeng Wang, Wenyan Sun, Yang Liu.
A PK/PD model of saxagliptin: to simulate its pharmacokinetics and pharmacodynamics in healthy adults and patients with impaired hepatic function
[J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(2): 119-132.
|
[3] |
Peili Jiao, Yiyan Li, Xing Wu, Yuxi Wang, Beibei Mao, Hongwei Jin, Lihe Zhang, Liangren Zhang, Zhenming Liu.
Structure-based design and biological evaluation of novel mTOR inhibitors as potential anti-cervical agents
[J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(9): 603-616.
|
[4] |
Wen Jiang, Chao Sun, Jue Wang, Qian Xin, Kailin Li, Tonggang Qi, Yun Luan.
Protective effect of baicalin on experimental pulmonary arterial hypertension through inhibition of pulmonary vascular remodeling
[J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(10): 719-728.
|
[5] |
Xiwei Ji, Zisheng Kang, Yun Li, Xiping Yang, Xifeng Ma, Chongtie Shi, Yuan Lv.
An established LC-MS/MS method and a developed PK model for the study of pharmacokinetic properties of benapenem in infected mice
[J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(11): 802-811.
|
[6] |
Haixiu Jiang, Yanqing Guan, Xiaotian Zhang, Ya Han, Ningning Guo, Hong Wang, Shizhong Chen.
Analysis on molecular interaction mechanism of four hapten flavonoids in Shuang-huang-lian powder injection with bovine serum albumin
[J]. Journal of Chinese Pharmaceutical Sciences, 2017, 26(5): 366-371.
|
[7] |
Ya Chen, Hongwei Jin, Liangren Zhang, Zhenming Liu.
Molecular models of different states of the human multidrug resistance protein 4 (MRP4/ABCC4)
[J]. Journal of Chinese Pharmaceutical Sciences, 2016, 25(6): 428-437.
|
[8] |
Zhenzhen Mou, Siyuan Wang, Qinghong Su, Yin Yuan, Jingyun Li, Lijie Wang, Qingyu Yao, Shuangmin Ji, Wei Lu, Tianyan Zhou.
Cabozantinib enhances the response of NSCLC cells with wild-type EGFR to erlotinib and pharmacodynamic modeling of their sequential combinations
[J]. Journal of Chinese Pharmaceutical Sciences, 2016, 25(11): 799-813.
|
[9] |
Jianguo Li, Fen Pei, Wenjie Zhu, Hongwei Jin, Yongjuan Zhao, Liangren Zhang, Honcheung Lee, Lihe Zhang.
Investigation of the effect of 2'-substitution of NMN analogues on CD38 NADase inhibitory activity
[J]. Journal of Chinese Pharmaceutical Sciences, 2015, 24(8): 514-523.
|
[10] |
Yi Liang, Fen Pei, Hong Wang, Shizhong Chen.
Two alkaloids as α-amylase inhibitors: enzyme kinetics and molecular modeling investigations
[J]. Journal of Chinese Pharmaceutical Sciences, 2015, 24(2): 80-87.
|
[11] |
Hechuan Wang, Liang Li, Yupeng Ren, Tianyan Zhou, Wei Lu.
Model-based meta-analysis of pharmacokinetics of direct-acting antiviral agents, ledipasvir and sofosbuvir, in healthy subjects and chronic HCV patients
[J]. Journal of Chinese Pharmaceutical Sciences, 2015, 24(12): 773-779.
|
[12] |
Bo Yu, Hongwei Jin, Liangren Zhang*, Chao Wang* .
Pharmacophore identification and validation for human nAChR α7 agonists
[J]. , 2013, 22(5): 393-402.
|
[13] |
Zhi-Yu Yang, Wei Lv, Ran Tian, Hong-Wei Jin, Hui-Hui Zeng*.
Insights into the discovery of new 5-HT1A receptor ligands: receptor based pharmacophore
[J]. , 2009, 18(2): 151-155.
|
[14] |
Peng Hui, Yang Chunzheng*, Qi Jing, Liang Wei, Huang Niu, Guo Zongru .
Structure-activity Relationship of Phenothiazines for Inhibition of Protein Kinase C and Reversal of Multidrug Resistance
[J]. , 2002, 11(2): 11-18.
|